AI-Designed Mutation-Resistant Broad Neutralization Antibodies Against Multiple SARS-CoV-2 Strains

Artificial intelligence has the advantage of allowing for the analysis of big and ever-changing data such as the dynamic genome information of a constantly evolving virus. In this study, we have applied AI technologies in the computational design of broad neutralization antibodies against over 1300 different historical SARS-CoV-2 strains with very small computational cost. The…

Ainnocence will be part of the Innovation Roundtables

We are excited to share that #ainnocence founder and CEO Lurong Pan will be part of the Innovation Roundtables, AI for Drug Discovery: Accelerating Knowledge in Rare Disease. At the RARE-X Exchange Innovation Summit. Find Dr. Pan at table 19 this Thursday, September 15th between 11:30-12:45 pm. #ai #innovation #rarex #drugdiscovery